Cita APA

Rubio-Terrés, C., Aguado, J. M., Almirante, B., Cobo, J., Grau Cerrato, S., Salavert, M., . . . Rubio-Rodríguez, D. (2019). Extended-pulsed fidaxomicin versus vancomycin in patients 60 years and older with Clostridium difficile infection: Cost-effectiveness analysis in Spain.

Citación estilo Chicago

Rubio-Terrés, Carlos, José María Aguado, Benito Almirante, Javier Cobo, Santiago Grau Cerrato, M. Salavert, Elena González Antona Sánchez, Cristina López Gutiérrez, y Darío Rubio-Rodríguez. Extended-pulsed Fidaxomicin Versus Vancomycin in Patients 60 Years and Older With Clostridium Difficile Infection: Cost-effectiveness Analysis in Spain. 2019.

Cita MLA

Rubio-Terrés, Carlos, et al. Extended-pulsed Fidaxomicin Versus Vancomycin in Patients 60 Years and Older With Clostridium Difficile Infection: Cost-effectiveness Analysis in Spain. 2019.